Micro-organisms have recently received broad attention as sources of novel lipids. An increased understanding of the effects of fats and oils and their composition on the metabolism and on health has shifted the focus towards the use of lipids for disease treatment and prevention and for the promotion of good health. A large range of lipidic products produced by yeast is known today. Ergosterol and its metabolic precursors are major lipidic components of industrial and commercial interest. Having in mind the aim to increase the productivity of ergosterol and its precursor metabolites, both the knowledge of regulatory mechanisms of the biosynthetic pathway and its interactions with other lipid pathways like those of sphingolipids, phospholipids and fatty acids are crucial.
Skip Nav Destination
Article navigation
October 2005
- Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
Conference Article|
October 26 2005
Interactions of the ergosterol biosynthetic pathway with other lipid pathways
M. Veen;
M. Veen
1
1Institut für Biotechnologie, Technische Universität Berlin, FG Mikrobiologie und Genetik, Gustav-Meyer-Allee 25, D-13355 Berlin, Germany
Search for other works by this author on:
C. Lang
C. Lang
2
1Institut für Biotechnologie, Technische Universität Berlin, FG Mikrobiologie und Genetik, Gustav-Meyer-Allee 25, D-13355 Berlin, Germany
2To whom correspondence should be addressed (email c.lang@lb.tu-berlin.de).
Search for other works by this author on:
Biochem Soc Trans (2005) 33 (5): 1178–1181.
Article history
Received:
May 31 2005
Citation
M. Veen, C. Lang; Interactions of the ergosterol biosynthetic pathway with other lipid pathways. Biochem Soc Trans 26 October 2005; 33 (5): 1178–1181. doi: https://doi.org/10.1042/BST0331178
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.